Sonja Strah-Pleynet
Arena Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Neurotransmitter Receptor Influence on Behavior, Receptor Mechanisms and Signaling, Sleep and Wakefulness Research, Pharmacological Receptor Mechanisms and Effects, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Discovery of 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (Nelotanserin) and Related 5-Hydroxytryptamine2AInverse Agonists for the Treatment of Insomnia(2010)22 cited
- → Discovery and Structure−Activity Relationship of 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine2A Receptor Inverse Agonist for the Treatment of Arterial Thrombosis(2010)12 cited
- → Identification of fused bicyclic heterocycles as potent and selective 5-HT2A receptor antagonists for the treatment of insomnia(2012)12 cited
- → Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists(2014)9 cited
- → Solubilized phenyl-pyrazole ureas as potent, selective 5-HT2A inverse-agonists and their application as antiplatelet agents(2009)8 cited
- → Synthesis and in Vivo Evaluation of Phenethylpiperazine Amides: Selective 5-Hydroxytryptamine2AReceptor Antagonists for the Treatment of Insomnia(2010)6 cited
- DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT(2004)